Global /United States /Healthcare /Drug Manufacturers - General /SKVI
chevron_leftBack
Skinvisible, Inc. logo

Skinvisible, Inc.

SKVI
OTCMKTS: SKVI Delayed
0.2000USD -33%
As of 18 June 2026, Skinvisible, Inc. has a market cap of $1.62M USD, ranking #47693 globally and #6072 in the United States. It ranks #4226 in the Healthcare sector, and #1335 in the Drug Manufacturers - General industry.
Global Rank
47693
Country Rank
6072
Sector Rank
4226
Industry Rank
1335
Key Stats
Market Cap
$1.62MUSD
Enterprise Value
$7.4MUSD
Revenue (TTM)
$20.0KUSD
EBITDA (TTM)
-$476.08KUSD
Net Income (TTM)
-$1.06MUSD
PS Ratio
81.1
PB Ratio
-0.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Terry Howlett open_in_new
Employees
2
Founded
1998
Website
skinvisible.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-33% 21% -25% -25% -14% 30%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
SKVI
Skinvisible Inc
ISIN: US8307032032
Shares Out.:
5.404M1 Shares Float: 5.213M2
TV:
SA:
YF:
GF:
BA:
MS:
0.2000 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Skinvisible, Inc.

Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women’s health, pain management, and other markets. The company’s flagship product includes Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. It also develops and licenses prescription and over-the-counter products to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company also develops formulations for the treatment of obesity, and dermatology related conditions, such as rare skin disorders. Skinvisible, Inc. was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. The company was incorporated in 1998 and is based in Las Vegas, Nevada.

Similar Companies

Industry: Drug Manufacturers - General (United States)
Name
Market Cap diff.
PE
LLY
$761.68B
47M%
38.1
JNJ
$547.28B
34M%
26.4
ABBV
$360.63B
22M%
97.4
MRK
$274.03B
17M%
15.1
PFE
$149.38B
9M%
19.5
$117.58B
7M%
16.8
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
$323.08B
256.25B CHF
20M%
19.9
AZN
$289.5B
215.59B GBP
18M%
27.6
NOVN
$275.99B
218.9B CHF
17M%
20.5
NOVO-B
$182.62B
1.18T DKK
11M%
11.5
SAN
$110.61B
95.26B EUR
7M%
19.9
GSK
$108.71B
80.96B GBP
7M%
14.6
chevron_leftBack